Report-store Details

  • Home
  • Report-store Details
Contact Us
+1 (732) 526 1166
India: 040-46013143

Email Us

Report Type : Therapy Reports
Report Category : Cardiovascular
Report Subcategory : Acute Coronary Syndrome
Price : 2999.00
Date : December 2021
Acute Coronary Syndrome : Global Market Landscape till 2030 - Epidemiology, Drugs, Trials, Technology, Companies, News, Deals, Patents, Drug Sales & Forecast, Future Events, DMF, and Manufacturing

Acute Coronary Syndrome
Acute coronary syndrome (ACS) is a condition in which there is reduced blood flow in the coronary arteries that leads to an improper function of part of the heart muscle. Acute Coronary Syndrome is further classified into (1) Non-ST-elevation myocardial infarction (NSTEMI), (2) ST-elevation MI (STEMI) and (3)Unstable angina.

Top 10 Companies:
Johnson & Johnson
F. Hoffmann-La Roche Ltd
Pfizer Inc
Novartis AG
Merck & Co Inc
GlaxoSmithKline Plc
Bristol-Myers Squibb Co
AstraZeneca Plc

Have a business Query? Let's Talk.

Email : or Call : +1 (732) 526 1166
India: 040-46013143

Get The Latest Updates

Signup For Newsletter

(c) 2021 Sciinov Group - All rights reserved.